Rezultaty
At least 500 mg of reactive ncAA AhA will be produced by biotechnological means
Bioproduction of unmodified spidroinsAt least 500 mg of unmodified spidroins will be biologically produced
Production of activated affinity ligandsAt least 250 mg of each activated affinity ligand will be attained The affinity ligands selective for factor VIII Mabs VLPs and protein A will be produced and modified with DBCO for further modification of labeled spidroin
Data Management PlanA detailed Data Management Plan will be created at the beginning of the project to ensure that all data is findable accessible interoperable and reusable FAIR The plan will be harmonized with a knowledge protection plan IPR plan
Dissemination and Exploitation Plan at the end of the first Reporting Period RP1 M12
Publikacje
Autorzy:
Charlotte Leonhardt
Opublikowane w:
2021
Wydawca:
Universitat Bayreuth
Autorzy:
Amelie Linder
Opublikowane w:
2022
Wydawca:
Universitat Bayreuth
Autorzy:
José Pedro Fradique Lourenço Dias Dinis
Opublikowane w:
2022
Wydawca:
Universidade NOVA de Lisboa
Autorzy:
Costa, Carlos Filipe Santos; Barbosa, Arménio J. M.; Dias, Ana Margarida Gonçalves Carvalho; Roque, Ana Cecília A.
Opublikowane w:
Biotechnology Advances, Numer 59, 2022, Strona(/y) 107986, ISSN 0734-9750
Wydawca:
Elsevier BV
DOI:
10.1016/j.biotechadv.2022.107986
Wyszukiwanie danych OpenAIRE...
Podczas wyszukiwania danych OpenAIRE wystąpił błąd
Brak wyników